Literature DB >> 34287746

Hereditary and non-hereditary etiologies associated with extensive brain calcification: case series.

András Salamon1, Dénes Zádori1, Anikó Ujfalusi2, László Szpisjak1, Melinda Lukács1, Brigitta Bihari3, Noémi Szépfalusi1, Viola Luca Németh1, Zoltán Maróti4, Emese Horváth5, István Balogh2, Csaba Bereczki4, Péter Klivényi1, Tibor Kalmár6.   

Abstract

Cerebral calcification may be caused by several potentially treatable conditions, however, in most cases it does not receive special attention in clinical practice. From the point of view of etiology, the diseases associated with cerebral calcification can be divided into two main groups: idiopathic (mostly incurable) and secondary (potentially treatable). The first group includes mainly the hereditary diseases identified before 2021 (primary familial brain calcification subtypes, previously known as Fahr's disease or Fahr's syndrome). In contrast, the second group includes diseases with cerebral calcification that develop generally as a consequence of metabolic/endocrine/autoimmune abnormalities. The aim of our research was to present hereditary and non-hereditary etiologies associated with extensive brain calcification. We compare the detailed clinical, radiological and laboratory results of 6 patients with prominent cerebral calcification identified in our clinic in the last 3 years (idiopathic and secondary etiologies as well). Our research draws attention to the complexity of the etiologies in the context of cerebral calcification. We recommend, beside NGS-based sequence analyses, the application of array comparative genomic hybridization as well, to identify potential genetic etiologies associated with brain calcification.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Brain calcification; Fahr’s syndrome; Genetic; Idiopathic basal ganglia calcification; Mosaicism; Primary familial brain calcification

Mesh:

Year:  2021        PMID: 34287746     DOI: 10.1007/s11011-021-00790-9

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  27 in total

1.  Biallelic loss-of-function mutations in JAM2 cause primary familial brain calcification.

Authors:  Zhidong Cen; You Chen; Si Chen; Hong Wang; Dehao Yang; Hongmei Zhang; Hongwei Wu; Lebo Wang; Siyang Tang; Jia Ye; Jian Shen; Haotian Wang; Feng Fu; Xinhui Chen; Fei Xie; Peng Liu; Xuan Xu; Jianzhi Cao; Pan Cai; Qinqing Pan; Jieying Li; Wei Yang; Peng-Fei Shan; Yuezhou Li; Jing-Yu Liu; Baorong Zhang; Wei Luo
Journal:  Brain       Date:  2020-02-01       Impact factor: 13.501

Review 2.  MYORG Mutations: a Major Cause of Recessive Primary Familial Brain Calcification.

Authors:  Max Bauer; Dolev Rahat; Elad Zisman; Yuval Tabach; Alexander Lossos; Vardiella Meiner; David Arkadir
Journal:  Curr Neurol Neurosci Rep       Date:  2019-08-23       Impact factor: 5.081

Review 3.  Strio-pallido-dentate calcinosis: a diagnostic approach in adult patients.

Authors:  Sara Bonazza; Chiara La Morgia; Paolo Martinelli; Sabina Capellari
Journal:  Neurol Sci       Date:  2011-04-09       Impact factor: 3.307

4.  Autosomal dominant pseudohypoparathyroidism type Ib: a novel inherited deletion ablating STX16 causes loss of imprinting at the A/B DMR.

Authors:  Francesca M Elli; Luisa de Sanctis; Erika Peverelli; Paolo Bordogna; Barbara Pivetta; Gianmaria Miolo; Paolo Beck-Peccoz; Anna Spada; Giovanna Mantovani
Journal:  J Clin Endocrinol Metab       Date:  2014-01-17       Impact factor: 5.958

5.  Autosomal dominant pseudohypoparathyroidism type Ib is associated with a heterozygous microdeletion that likely disrupts a putative imprinting control element of GNAS.

Authors:  Murat Bastepe; Leopold F Fröhlich; Geoffrey N Hendy; Olafur S Indridason; Robert G Josse; Hiroyuki Koshiyama; Jarmo Körkkö; Jon M Nakamoto; Arlan L Rosenbloom; Arnold H Slyper; Toshitsugu Sugimoto; Agathocles Tsatsoulis; John D Crawford; Harald Jüppner
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

6.  Normocalcemic hyperparathyroidism and hypoparathyroidism in two community-based nonreferral populations.

Authors:  Natalie E Cusano; Naim M Maalouf; Patty Y Wang; Chiyuan Zhang; Serge C Cremers; Elizabeth M Haney; Douglas C Bauer; Eric S Orwoll; John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2013-05-20       Impact factor: 5.958

7.  Novel SLC20A2 mutations identified in southern Chinese patients with idiopathic basal ganglia calcification.

Authors:  Wan-Jin Chen; Xiang-Ping Yao; Qi-Jie Zhang; Wang Ni; Jin He; Hong-Fu Li; Xin-Yi Liu; Gui-Xian Zhao; Shen-Xing Murong; Ning Wang; Zhi-Ying Wu
Journal:  Gene       Date:  2013-08-11       Impact factor: 3.688

Review 8.  Basal ganglia calcifications (Fahr's syndrome): related conditions and clinical features.

Authors:  Giulia Donzuso; Giovanni Mostile; Alessandra Nicoletti; Mario Zappia
Journal:  Neurol Sci       Date:  2019-07-02       Impact factor: 3.307

9.  Prevalence of brain calcifications in a Brazilian cohort: A retrospective study in radiology services.

Authors:  Matheus Fernandes de Oliveira; Edison Barros E Silva; João Ricardo Mendes de Oliveira
Journal:  Dement Neuropsychol       Date:  2013 Apr-Jun

10.  MYORG-related disease is associated with central pontine calcifications and atypical parkinsonism.

Authors:  Viorica Chelban; Miryam Carecchio; Gillian Rea; Abdalla Bowirrat; Salman Kirmani; Luca Magistrelli; Stephanie Efthymiou; Lucia Schottlaender; Jana Vandrovcova; Vincenzo Salpietro; Ettore Salsano; Davide Pareyson; Luisa Chiapparini; Farida Jan; Shahnaz Ibrahim; Fatima Khan; Zul Qarnain; Stanislav Groppa; Nin Bajaj; Bettina Balint; Kailash P Bhatia; Andrew Lees; Patrick J Morrison; Nicholas W Wood; Barbara Garavaglia; Henry Houlden
Journal:  Neurol Genet       Date:  2020-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.